WN1703   Click here for help

GtoPdb Ligand ID: 13463

Synonyms: compound 16c [PMID: 28918097] | WN-1703 | XOR inhibitor 16c
Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: WN1703 is an inhibitor of xanthine dehydrogenase (XDH, a.k.a. XOR) [1,3]. This enzyme is the target of the hyperuricemia/gout drugs febuxostat and allopurinol.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 1
Rotatable bonds 5
Topological polar surface area 79.93
Molecular weight 298.34
XLogP 2.07
No. Lipinski's rules broken 0

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CC(C)CN(C)C1=CC=C(C=C1C#N)N2C=C(C=N2)C(=O)O
Isomeric SMILES CC(C)CN(C)C1=C(C=C(C=C1)N2C=C(C=N2)C(=O)O)C#N
InChI InChI=1S/C16H18N4O2/c1-11(2)9-19(3)15-5-4-14(6-12(15)7-17)20-10-13(8-18-20)16(21)22/h4-6,8,10-11H,9H2,1-3H3,(H,21,22)
InChI Key HAJKHKHBTDJWQP-UHFFFAOYSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

Immunopharmacology Comments
In a rat gout model WN1703 relieves disease symptoms by down-regulating the NLRP3/caspase-1 and TLR4/MyD88/NF-κB inflammatory signalling pathways [2]. WN1703 attenuates circulating TNF-α and IL-1β levels in vivo.